Non-Current Assets
Intangible Assets Gross (Excluding Goodwill)
Pfizer Intangible Assets Gross (Excluding Goodwill) decreased by 0.5% to $122.66B in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 3.0%, from $126.49B to $122.66B. Over 4 years (FY 2020 to FY 2024), Intangible Assets Gross (Excluding Goodwill) shows an upward trend with a 10.9% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryGrowth
SignalHigher is better
VolatilityStable
First reportedQ4 2015
Last reportedQ3 2025
How to read this metric
Growth suggests successful acquisition of intellectual property or investment in proprietary technology platforms.
Detailed definition
This is the total cost of identifiable intangible assets such as patents, trademarks, and software, excluding goodwill....
Peer comparison
Common for technology, financial services, and brand-heavy companies.
Metric ID:
intangible_assets_gross_excluding_goodwillHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $82.12B | $81.85B | $80.98B | $86.36B | $86.14B | $85.67B | $101.92B | $101.18B | $101.77B | $101.68B | $127.73B | $126.98B | $126.61B | $126.49B | $122.96B | $122.75B | $123.22B | $122.66B |
| QoQ Change | — | -0.3% | -1.1% | +6.6% | -0.2% | -0.6% | +19.0% | -0.7% | +0.6% | -0.1% | +25.6% | -0.6% | -0.3% | -0.1% | -2.8% | -0.2% | +0.4% | -0.5% |
| YoY Change | — | — | — | — | +4.9% | +4.7% | +25.9% | +17.2% | +18.1% | +18.7% | +25.3% | +25.5% | +24.4% | +24.4% | -3.7% | -3.3% | -2.7% | -3.0% |
Range$80.98B – $127.73B
CAGR+9.9%
Avg YoY Growth+12.6%
Median YoY Growth+17.6%
Intangible Assets Gross (Excluding Goodwill) at Other Companies
Frequently Asked Questions
- What is Pfizer's intangible assets gross (excluding goodwill)?
- Pfizer (PFE) reported intangible assets gross (excluding goodwill) of $122.66B in Q3 2025.
- How has Pfizer's intangible assets gross (excluding goodwill) changed year-over-year?
- Pfizer's intangible assets gross (excluding goodwill) decreased by 3.0% year-over-year, from $126.49B to $122.66B.
- What is the long-term trend for Pfizer's intangible assets gross (excluding goodwill)?
- Over 4 years (2020 to 2024), Pfizer's intangible assets gross (excluding goodwill) has grown at a 10.9% compound annual growth rate (CAGR), from $81.33B to $122.96B.
- What does intangible assets gross (excluding goodwill) mean?
- The total cost of non-physical assets like patents and software, excluding goodwill.